Korea Aesthetic Services Market Size & Outlook, 2026-2034
Korea Aesthetic Services Market Insights
- Based on Deep Market Insights findings, the Korea Aesthetic Services Market reached USD 81.3 Million in 2025 and is estimated to attain USD 213.56 Million by 2034.
- From 2026 to 2034, the Korea market is expected to grow at a steady CAGR of 11.35%.
- Within the Service type category, Minimally Invasive Injectables dominated in 2025 in terms of market size contribution.
- Over the forecast period, Surgical Procedures is forecasted to deliver the fastest growth, positioning it as the most lucrative Service type segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, Korea represented 0.79% of the overall global Aesthetic Services Market size.
- United States is projected to lead the global Aesthetic Services Market size by 2034.
- Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
- China is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 1844.2 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 81.3 Million |
| Market Size In 2034 | USD 213.56 Million |
| Largest segment | Minimally Invasive Injectables |
| Units | Revenue in USD Million |
| CAGR | 11.35% (2026-2034) |
| Segmnetation Covered | |
| Service type |
|
| Provider |
|
| End user |
|
| Pricing tier |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Korea Aesthetic Services Market Service type 2026-2034 (USD Million)
| Service type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Minimally Invasive Injectables | XX.x | XX.x | XX.x | 36.63 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Lasers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Surgical Procedures | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Korea Aesthetic Services Market Provider 2026-2034 (USD Million)
| Provider | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinics | XX.x | XX.x | XX.x | 36.62 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hospitals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Med-spas | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Korea Aesthetic Services Market End user 2026-2034 (USD Million)
| End user | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age Groups | XX.x | XX.x | XX.x | 52.7 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gender | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Korea Aesthetic Services Market Pricing tier 2026-2034 (USD Million)
| Pricing tier | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premium | XX.x | XX.x | XX.x | 51.06 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Mass Market | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.